Partially desulphated glycosaminoglycan derivatives are described,
particularly heparin, and more particularly formula (I) compounds where
the U, R and R.sub.1 groups have the meanings indicated in the
description. Said glycosaminoglycan derivatives are endowed with
antiangiogenic and heparanase-inhibiting activity ans are devoid of
anticoagulant activity.
